Jpmorgan Chase & CO Atrion Corp Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Atrion Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 20,644 shares of ATRI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,644

Previous 21,479 3.89%

Holding current value

Previous $9.96 Million 6.2%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$381.09 - $495.99 $318,210 - $414,151	-835 Reduced 3.89%	20,644 $9.34 Million
Q1 2024 May 10, 2024	BUY	$308.3 - $463.55 $4.99 Million - $7.51 Million	16,201 Added 306.95%	21,479 $9.96 Million
Q4 2023 Feb 12, 2024	BUY	$289.29 - $409.7 $930,645 - $1.32 Million	3,217 Added 156.09%	5,278 $2 Million
Q3 2023 Nov 14, 2023	SELL	$401.2 - $581.79 $85,856 - $124,503	-214 Reduced 9.41%	2,061 $851,000
Q2 2023 Aug 11, 2023	BUY	$500.0 - $659.0 $101,000 - $133,118	202 Added 9.74%	2,275 $1.29 Million
Q1 2023 May 18, 2023	BUY	$565.0 - $694.87 $960,500 - $1.18 Million	1,700 Added 455.76%	2,073 $1.3 Million
Q1 2023 May 11, 2023	SELL	$565.0 - $694.87 $744,105 - $915,143	-1,317 Reduced 77.93%	373 $234,000
Q4 2022 Feb 13, 2023	BUY	$551.1 - $688.5 $86,522 - $108,094	157 Added 10.24%	1,690 $946,000
Q3 2022 Nov 14, 2022	BUY	$545.43 - $680.3 $37,089 - $46,260	68 Added 4.64%	1,533 $866,000
Q2 2022 Aug 11, 2022	BUY	$605.0 - $763.25 $139,150 - $175,547	230 Added 18.62%	1,465 $921,000
Q1 2022 May 11, 2022	SELL	$601.4 - $763.0 $244,168 - $309,778	-406 Reduced 24.74%	1,235 $881,000
Q4 2021 Feb 10, 2022	BUY	$650.15 - $802.0 $483,711 - $596,688	744 Added 82.94%	1,641 $1.16 Million
Q3 2021 Nov 12, 2021	BUY	$594.24 - $758.0 $533,033 - $679,926	897 New	897 $626,000

Others Institutions Holding ATRI

# of Institutions

109

Shares Held

1.12M

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Atrion Corp Transaction History